查看更多>>摘要：Three-dimensional(3D)printing is an innovative manufacturing method with the potential to revolutionize topical and transdermal dosage forms.Nowadays,it is established that Vat-based photopolymerization(VP)3D printing technologies offer superior printing efficiency and versatility compared to other 3D printing technologies available on the market.However,there are some limitations that impair their full application in pharmaceutical contexts,such as the lack of a range of biocompatible materials for topical and transdermal applications.This review article explores all types of VP-based 3D printing and discusses the relevance of implementing this kind of technology.We start with a detailed description of the printing process,focusing on the commercial materials available and lab-made resins proposed by different authors.We also review recent studies in this field,which mainly focus on the fabrication of transdermal devices based on microneedle arrays.In the future,it is expected that the manufacturers of 3D printers invest in modifications to the printing apparatus to allow the simultaneous printing of different resins and/or compound types,which will open frontiers to the personalization of treatment approaches.
查看更多>>摘要：Ferroptosis is a nonapoptotic form of cell death characterized by iron dependence and lipid peroxidation.Ferroptosis is involved in a range of pathological processes,such as cancer.Many studies have confirmed that ferroptosis plays an essential role in inhibiting cancer cell proliferation.In addition,a series of small-molecule compounds have been developed,including erastin,RSL3,and FIN56,which can be used as ferroptosis inducers.The combination of ferroptosis inducers with anticancer drugs can produce a significant synergistic effect in cancer treatment,and patients treated with these combinations exhibit a better prognosis than patients receiving traditional therapy.Therefore,a thorough understanding of the roles of ferroptosis in cancer is of great significance for the treatment of cancer.This review mainly elaborates the molecular biological characteristics and mechanism of ferroptosis,summarizes the function of ferroptosis in cancer development and treatment,illustrates the application of ferroptosis in patient's prognosis prediction and drug discovery,and discusses the prospects of targeting ferroptosis.
查看更多>>摘要：Asthma is a widespread public health concern,with an increasing incidence.Despite the implementation of current treatment strategies,asthma control,particularly for severe cases,remains suboptimal.Recent research has revealed the encouraging prospects of extracellular vesicles(EVs)secreted by mesenchymal stem cells(MSCs)as a viable therapeutic option for alleviating asthma symptoms.Therefore,the present review aims to provide an overview of the current progress and the therapeutic mechanisms of using MSC-derived EVs(MSC-EVs)for asthma treatment.Additionally,different administration approaches for EVs and their impacts on biodistribution and the curative outcomes of EVs are summarized.Notably,the potential benefits of nebulized inhalation of MSC-EVs are addressed.Also,the possibilities and challenges of using MSC-EVs for asthma treatment in clinics are highlighted.Overall,this review is intended to give new insight into the utilization of MSC-EVs as a potential biological drug for asthma treatment.
查看更多>>摘要：Inflammatory bowel diseases(IBD)significantly contribute to high mortality globally and negatively affect patients'qualifications of life.The gastrointestinal tract has unique anatomical characteristics and physiological environment limitations.Moreover,certain natural or synthetic anti-inflammatory drugs are associated with poor targeting,low drug accumulation at the lesion site,and other side effects,hindering them from exerting their therapeutic effects.Colon-targeted drug delivery systems represent attractive alternatives as novel carriers for IBD treatment.This review mainly discusses the treatment status of IBD,obstacles to drug delivery,design strategies of colon-targeted delivery systems,and perspectives on the existing complementary therapies.Moreover,based on recent reports,we summarized the therapeutic mechanism of colon-targeted drug delivery.Finally,we addressed the challenges and future directions to facilitate the exploitation of advanced nanomedicine for IBD therapy.
查看更多>>摘要：Acne vulgaris ranks as the second most prevalent dermatological condition worldwide,and there are still insufficient safe and reliable drugs to treat it.Cryptotanshinone(CTS),a bioactive compound derived from traditional Chinese medicine Salvia miltiorrhiza,has shown promise for treating acne vulgaris due to its broad-spectrum antimicrobial and significant anti-inflammatory properties.Nevertheless,its local application is hindered by its low solubility and poor skin permeability.To overcome these challenges,a carrier-free pure drug self-assembled nanosystem is employed,which can specifically modify drug molecules based on the disease type and microenvironment,offering a potential for more effective treatment.We designed and synthesized three distinct structures of cationic CTS-peptide conjugates,creating self-assembled nanoparticles.This study has explored their self-assembly behavior,skin permeation,cellular uptake,and both in vitro and in vivo anti-acne effects.Molecular dynamics simulations revealed these nanoparticles form through intermolecular hydrogen bonding and π-π stacking interactions.Notably,self-assembled nanoparticles demonstrated enhanced bioavailability with higher skin permeation and cellular uptake rates.Furthermore,the nanoparticles exhibited superior anti-acne effects compared to the parent drug,attributed to heightened antimicrobial activity and significant downregulation of the MAPK/NF-κB pathway,leading to reduced expression of pro-inflammatory factors including TNF-α,IL-1β and IL-8.In summary,the carrier-free self-assembled nanoparticles based on CTS-peptide conjugate effectively address the issue of poor skin bioavailability,offering a promising new approach for acne treatment.
查看更多>>摘要：Small-molecule prodrug nanoassembly technology with a unique advantage in off-target toxicity reduction has been widely used for antitumor drug delivery.However,prodrug activation remains a rate-limiti ng step for exerting therapeutic actions,which requires to quickly reach the minimum valid concentrations of free drugs.Fortunately,we find that a natural compound(BL-193)selectively improves the chemotherapy sensitivity of breast cancer cells to podophyllotoxin(PPT)at ineffective dose concentrations.Based on this,we propose to combine prodrug nanoassembly with chemotherapy sensitization to fully unleash the chemotherapeutic potential of PPT.Specifically,a redox-sensitive prodrug(PSSF)of PPT is synthesized by coupling 9-fluorenyl-methanol(Fmoc-OH)with PPT linked via disulfide bond.Intriguingly,PSSF with a π-conjugated structure readily co-assembles with BL-193 into stable nanoassembly.Significantly,BL-193 serves as an excellent chemosensitizer that creates an ultra-low-dose chemotherapeutic window for PPT.Moreover,prodrug design and precise hybrid nanoassembly well manage off-target toxicity.As expected,such a BL-193-empowered prodrug nanoassembly elicits potent antitumor responses.This study offers a novel paradigm to magnify chemotherapy efficacy-toxicity benefits.
查看更多>>摘要：Intracellular bacteria can multiply inside host cells and manipulate their biology,and the efficacy of traditional antibiotic drug therapy for intracellular bacteria is limited by inadequate drug accumulation.Fighting against these stealthy bacteria has been a long-standing challenge.Here,a system of stimuli-responsive lactoferrin(Lf)nanoparticles is prepared using protein self-assembly technology to deliver broad-spectrum antibiotic rifampicin(Rif)(Rif@Lf NPs)for enhanced infection therapy through targeted elimination of intracellular bacteria.Compared to Rif@BSA NPs,the Rif@Lf NPs can specifically target macrophages infected by bacteria,thus increasing the accumulation of Rif within macrophages.Subsequently,Rif@Lf NPs with positive surface charge further displayed targeted adherence to the bacteria within macrophages and released Rif rapidly in a redox-responsive manner.Combined with the antibacterial activities of Lf and Rif,the Rif@Lf NPs showed broad-spectrum antibiotic abilities to intracellular bacteria and biofilms.As a result,the Rif@Lf NPs with high safety exhibited excellent therapeutic efficacy in the disease models of subcutaneous infection,sepsis,and bacterial keratitis.Taken together,the antibiotic-loaded Lf nanoparticles present a promising platform to combat pathogen infections through targeted elimination of intracellular bacteria.
查看更多>>摘要：Alzheimer's disease is a neurodegenerative disease induced by multiple interconnected mechanisms.Peptide drug candidates with multi-modal efficacy generated from fusion strategy are suitable for addressing multi-facet pathology.However,clinical translation of peptide drugs is greatly hampered by their low permeability into brain.Herein,a hybrid peptide HNSS is generated by merging two therapeutic peptides(SS31 and S-14 G Humanin(HNG)),using a different approach from the classical shuttle-therapeutic peptide conjugate design.HNSS demonstrated increased bio-permeability,with a 2-fold improvement in brain distribution over HNG,thanks to its structure mimicking the design of signal peptide-derived cell-penetrating peptides.HNSS efficiently alleviated mitochondrial dysfunction through the combined effects of mitochondrial targeting,ROS scavenging and p-STAT3 activation.Meanwhile,HNSS with increased Aβ affinity greatly inhibited Aβ oligomerization/fibrillation,and interrupted Aβ interaction with neuron/microglia by reducing neuronal mitochondrial Aβ deposition and promoting microglial phagocytosis of Aβ.In 3× Tg-AD transgenic mice,HNSS treatment efficiently inhibited brain neuron loss and improved the cognitive performance.This work validates the rational fusion design-based strategy for bio-permeability improvement and efficacy amplification,providing a paradigm for developing therapeutic peptide candidates against neurodegenerative disease.
查看更多>>摘要：Leucine-rich α-2 glycoprotein 1(LRG1),a secreted glycoprotein,has been identified as significantly upregulated in renal fibrosis,potentially exacerbating the condition by enhancing TGF-β-Smad3-dependent signaling pathways.Herein,utilizing our developed LRG1-targeting peptide for LRG1 recruitment and lenalidomide for E3 ubiquitin ligase engagement,we developed an advanced proteolysis targeting chimera,ETTAC-2,specifically designed for LRG1 degradation.Our cellular degradation assays validated that ETTAC-2 effectively degraded LRG1 through a proteasome-dependent mechanism,achieving half-maximal degradation at a concentration of 8.38 μM.Furthermore,anti-fibrotic experiments conducted both in vitro and in vivo revealed that ETTAC-2 efficiently induced LRG1 degradation in fibrotic kidneys.This action effectively inhibited the TGF-β-Smad3 signaling pathway and diminished the secretion of fibrosis-associated proteins,consequently attenuating the progression of renal fibrosis.Our study highlights the pivotal role of LRG1 in renal fibrosis and positions ETTAC-2 as a promising therapeutic candidate for targeted LRG1 intervention.
查看更多>>摘要：Mesenchymal stem cells(MSCs)have emerged as promising candidates for idiopathic pulmonary fibrosis(IPF)therapy.Increasing the MSC survival rate and deepening the understanding of the behavior of transplanted MSCs are of great significance for improving the efficacy of MSC-based IPF treatment.Therefore,dual-functional Au-based nanoparticles(Au@PEG@PEI@TAT NPs,AuPPT)were fabricated by sequential modification of cationic polymer polyetherimide(PEI),polyethylene glycol(PEG),and transactivator of transcription(TAT)penetration peptide on AuNPs,to co-deliver retinoic acid(RA)and microRNA(miRNA)for simultaneously enhancing MSC survive and real-time imaging tracking of MSCs during IPF treatment.AuPPT NPs,with good drug loading and cellular uptake abilities,could efficiently deliver miRNA and RA to protect MSCs from reactive oxygen species and reduce their expression of apoptosis executive protein Caspase 3,thus prolonging the survival time of MSC after transplantation.In the meantime,the intracellular accumulation of AuPPT NPs enhanced the computed tomography imaging contrast of transplanted MSCs,allowing them to be visually tracked in vivo.This study establishes an Au-based dual-functional platform for drug delivery and cell imaging tracking,which provides a new strategy for MSC-related IPF therapy.
NETL
NSTL
万方数据